CODEXIS, INC. - 10-Q Filing
Codexis, Inc. reports third quarter 2026 financial results including research and development revenue components and updated liquidity position.
Tickers: $CDXS
More Regulatory news
- Stark Novus Financial Inc. - 8-K Filing
- Starling Oncology, Inc. - 8-K Filing
- Spero Therapeutics, Inc. - 8-K Filing
- BATTALION OIL CORP - 10-Q Filing
- INNOVATIVE FOOD HOLDINGS INC - 10-Q Filing
- Silexion Therapeutics Corp - 10-Q Filing
- DiaMedica Therapeutics Inc. - 10-Q Filing
- BATTALION OIL CORP - 8-K Filing
- Algorhythm Holdings, Inc. - 8-K Filing
- AMERICAN BATTERY MATERIALS, INC. - 10-Q Filing